Evidence map›Paper›PMID 37149582›Full record

Trial reportBMC oral health2023

Diode laser in management of loss of taste sensation in patients with post-COVID syndrome: a randomized clinical trial.

Alshaimaa Ahmed Shabaan, Islam Kassem, Aliaa Ibrahium Mahrous, Inass Aboulmagd, Mai Badrah, Mohamed Attalla, Shaimaa Mohsen Refahee

Open access · goldAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in BMC oral health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Alshaimaa Ahmed ShabaanOral & Maxillofacial Surgery Department, Faculty of Dentistry, Fayoum University, Fayoum, Egypt.ORCID 0000-0002-6105-4999
Islam KassemDepartment of Maxillofacial Surgery, Al-Alamin Hospital, Ministry of Health, Al-Alamin, Egypt.ORCID 0000-0002-1710-7862
Aliaa Ibrahium MahrousFixed Prosthodontic Department, Faculty of Dentistry, Fayoum University, Fayoum, Egypt.ORCID 0000-0002-7910-9759
Inass AboulmagdOral & Maxillofacial Radiology Department, Faculty of Dentistry, Fayoum University, Fayoum, Egypt.ORCID 0000-0003-0737-1384
Mai BadrahInternal Medicine, Faculty of Medicine, Alexandria University, Alexandria, Egypt.ORCID 0000-0003-3947-4476
Mohamed AttallaOral and Maxillofacial Department, IMAXFAX, Alexandria, Egypt.ORCID 0000-0002-8892-1351
Shaimaa Mohsen RefaheeOral & Maxillofacial Surgery Department, Faculty of Dentistry, Fayoum University, Fayoum, Egypt. smr11@fayoum.edu.eg.ORCID 0000-0002-7550-1913
Fayoum University · EGAlexandria University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveLoss of taste (ageusia) is a symptom observed following recovery from COVID-19 infection. The loss of taste and smell sensation may negatively affect patients' quality of life (QoL). The present study aimed to evaluate the effectiveness of the Diode Laser in managing loss of taste sensation in patients with post-COVID syndrome versus the placebo. MATERIAL AND

methodThe study sample was 36 patients who complained of persistent loss of taste sensation following COVID-19. The patients were randomly assigned to one of the two groups according to the received treatment: Group I (laser treatment) and Group II (light treatment), with each patient receiving a diode laser treatment or placebo from the same operator. Taste sensation was subjectively measured after treatment for four weeks.

resultsThe results demonstrated a significant difference between both groups regarding taste restoration after one month (p = 0.041), with Group II having a significantly higher percentage of cases 7 (38.9%) with partial taste restoration. In contrast, a significantly higher proportion of Group I 17 cases (94.4%) had complete taste restoration (p < 0.001).

conclusionThe present study concluded that using a Diode laser 810 nm aided in a more rapid recovery from loss of taste dysfunction.

Indexed as

AgeusiaCOVID-19Olfaction DisordersHumansLasers, SemiconductorQuality of LifeSARS-CoV-2SmellTasteTaste DisordersAgeusiaCOVID-19Diode laserLaser therapyLow-levelQuality of lifeRecovery of functionTaste disorder

Identifiers

PMID37149582
PMCPMC10163926
OpenAlexW4372325307

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.